Brief: Rallybio Announces Collaboration To Advance Therapeutic Solutions For Pregnant Individuals At Risk Of Fetal And Neonatal Alloimmune Thrombocytopenia

Rallybio

10/04/2024 22:02

April 10 (Reuters) - Rallybio Corp  RLYB.O :
    * RALLYBIO ANNOUNCES COLLABORATION TO ADVANCE THERAPEUTIC
SOLUTIONS FOR PREGNANT INDIVIDUALS AT RISK OF FETAL AND NEONATAL
ALLOIMMUNE THROMBOCYTOPENIA (FNAIT)
    * RALLYBIO CORP: TO RECEIVE FUNDING FOR FNAIT AWARENESS
INITIATIVE
AND EQUITY INVESTMENT FROM JOHNSON & JOHNSON
    * RALLYBIO CORP: RECEIVED AN EQUITY INVESTMENT OF $6.6
MILLION
FROM JOHNSON & JOHNSON INNOVATION - JJDC, INC
    * RALLYBIO CORP: ELIGIBLE TO RECEIVE ADDITIONAL PAYMENTS
UNDER
COLLABORATION

Source text for Eikon:  ID:nBw86Mt9Ga 
Further company coverage:  RLYB.O 

 ((Reuters.Briefs@thomsonreuters.com;))